B4GALNT3 Antibody | 26-378

B4GALNT3 Antibody | 26-378 | Gentaur UK, US & Europe Distribution

Host: Rabbit

Reactivity: Human, Mouse

Homology: N/A

Immunogen: Antibody produced in rabbits immunized with a synthetic peptide corresponding a region of human B4GALNT3.

Research Area: Membrane, Cancer, Signal Transduction

Tested Application: E, WB

Application: B4GALNT3 antibody can be used for detection of B4GALNT3 by ELISA at 1:62500. B4GALNT3 antibody can be used for detection of B4GALNT3 by western blot at 1 μg/mL, and HRP conjugated secondary antibody should be diluted 1:50, 000 - 100, 000.

Specificiy: N/A

Positive Control 1: Cat. No. 1201 - HeLa Cell Lysate

Positive Control 2: N/A

Positive Control 3: N/A

Positive Control 4: N/A

Positive Control 5: N/A

Positive Control 6: N/A

Molecular Weight: 115 kDa

Validation: N/A

Isoform: N/A

Purification: Antibody is purified by peptide affinity chromatography method.

Clonality: Polyclonal

Clone: N/A

Isotype: N/A

Conjugate: Unconjugated

Physical State: Liquid

Buffer: Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.

Concentration: batch dependent

Storage Condition: For short periods of storage (days) store at 4˚C. For longer periods of storage, store B4GALNT3 antibody at -20˚C. As with any antibody avoid repeat freeze-thaw cycles.

Alternate Name: B4GALNT3, B4GalNac-T3, FLJ16224, FLJ40362,

User Note: Optimal dilutions for each application to be determined by the researcher.

BACKGROUND: B4GALNT3 transfers N-acetylgalactosamine (GalNAc) onto glucosyl residues to form N, N-prime-diacetyllactosediamine (LacdiNAc, or LDN) , a unique terminal structure of cell surface N-glycans. It mediates the N, N'-diacetyllactosediamine formation on gastric mucosa.